Clinical Trials In Hawaii

Discover hundreds of clinical trials in Hawaii.
Search clinical trials in Hawaii by city, condition or phase.

e.g. Respiratory Diseases

Hawaii•Healthy volunteers: No

Filter results

Results: 198

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Honolulu, San Francisco, Palo Alto, Oaklandshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng

Recruiting

EARLY_PHASE1

Sponsor:

Practitioners Alliance Network

Location:

Kailua

Code:

NCT04599348

Conditions

Fibromyalgia

CFS

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HRG 80 Red Ginseng

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Recruiting

PHASE2

PHASE3

Sponsor:

Kevin Winthrop

Location:

Honolulu, San Francisco, Stanford, Portlandshow 23 more

Code:

NCT03672630

Conditions

Mycobacterium Avium Complex

Nontuberculous Mycobacterium Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Azithromycin

Ethambutol

Rifampin

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Honolulu, Corvallis, Northridge, Long Beachshow 41 more

Code:

NCT06260722

Conditions

Diabetes Mellitus, Type 2

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Retatrutide

Semaglutide

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

Recruiting

PHASE3

Sponsor:

Stichting European Myeloma Network

Location:

Honolulu, Fresno, West Hollywood, Los Angelesshow 26 more

Code:

NCT05028348

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Elotuzumab

Pomalidomide

Dexamethasone Oral

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Honolulu, 'Aiea, Lihue, Hiloshow 499 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Honolulu, 'Aiea, 'Ewa Beach, Kailuashow 629 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

REal-World Analyses of Stroke - Thrombus Occlusion REtrieval

Recruiting

Sponsor:

Microvention-Terumo, Inc.

Location:

Honolulu, Redwood City, Carmichael, Burbankshow 33 more

Code:

NCT04451525

Conditions

Acute Ischemic Stroke

Vessel Occlusion

Stroke

Ischemic

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

MicroVention Mechanical Thrombectomy Devices as first-line treatment

A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Recruiting

PHASE3

Sponsor:

Genmab

Location:

Honolulu, Berkeley, Bakersfield, Long Beachshow 53 more

Code:

NCT05578976

Conditions

Diffuse Large B-Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Epcoritamab

Cyclophosphamide

Rituximab

Vincristine

Doxorubicin

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Recruiting

PHASE3

Sponsor:

United Therapeutics

Location:

Honolulu, San Francisco, Stanford, Sacramentoshow 83 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer